Drugs / AGS-009
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00960362 | Jul 2009 → Dec 2011 | systemic lupus erythematosus | Argos Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGS-009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00960362 ↗ |
| Route | Intravenous | “administered intravenously (in the vein)” NCT00960362 ↗ |